Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00027599
What this trial is testing

APC8015 and Bevacizumab in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableWithdrawnNCT00963300
What this trial is testing

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04471727
What this trial is testing

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

Who this might be right for
Small-Cell Lung CancerNeuroendocrine Carcinoma
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 232
Testing effectiveness (Phase 2)Study completedNCT00025194
What this trial is testing

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002602
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,084
Not applicableEnded earlyNCT01737151
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer
Virginia Commonwealth University 19
Testing effectiveness (Phase 2)WithdrawnNCT00736164
What this trial is testing

Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00006365
What this trial is testing

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 138
Early research (Phase 1)Study completedNCT00753415
What this trial is testing

V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Who this might be right for
Non-Small Cell Lung CarcinomaBreast CancerMelanoma+5 more
Merck Sharp & Dohme LLC 37
Early research (Phase 1)Active Not RecruitingNCT05479578
What this trial is testing

Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) V8
Rashmi Verma, MD 7
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)WithdrawnNCT01859689
What this trial is testing

Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00038168
What this trial is testing

Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)UnknownNCT00002775
What this trial is testing

Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Herbert Irving Comprehensive Cancer Center 37
Early research (Phase 1)Study completedNCT00459407
What this trial is testing

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate

Who this might be right for
Adenocarcinoma of the ProstateStage I Prostate CancerStage II Prostate Cancer
National Cancer Institute (NCI) 50
Early research (Phase 1)Ended earlyNCT00788307
What this trial is testing

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Early research (Phase 1)Study completedNCT00482807
What this trial is testing

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Nebraska 9
Not applicableStudy completedNCT00243321
What this trial is testing

High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Virginia Commonwealth University 27
Not applicableActive Not RecruitingNCT00769223
What this trial is testing

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

Who this might be right for
Prostate CancerRadiation Toxicity
University of California, San Francisco 3,561
Next Page